COMMUNIQUÉS West-GlobeNewswire

GENFIT : Données positives de Phase 1b obtenues avec GNS561 en combinaison, dans une population de patients atteints de cholangiocarcinome lourdement prétraités
23/06/2026
Le médicament expérimental GNS561 a démontré un profil de sécurité et de tolérabilité favorable dans une étude de Phase 1b évaluant son potentiel en combinaison avec un inhibiteur de MEK (MEKi) Étude menée dans une [...]
GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma
23/06/2026
Investigational drug GNS561 showed a favorable safety and tolerability profile in a Phase 1b study evaluating its potential in combination with a MEK inhibitor (MEKi) Study conducted in a heavily pretreated, high - [...]
Wesley Pharmaceuticals Expands Longevity Portfolio with Launch of Three Essential Injectable Formulations
23/06/2026
Industry-leading compounding pharmacy introduces Methylcobalamin, Glutathione, and Magnesium Chloride to support cellular energy, metabolic health, and antioxidant defense ORLANDO, Fla., June 23, 2026 (GLOBE NEWSWIRE [...]
The XLH Network and Kyowa Kirin Launch the XLH Community Guidebook to Help People Navigate Lifelong Journey with XLH
23/06/2026
New online resource brings together practical information, community perspectives, and expert guidance tailored to people with XLH across ages and life stages PRINCETON, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Kyowa [...]
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
23/06/2026
Leading academic center with multi-hospital and multi-state health system deepens Company’s footprint in the Northeast U.S. The Company now has multiple accounts and hospitals that have adopted the LIBERTY System across [...]
Fieldstone Bio, TerraCore, and MIT Awarded U.S. Department of Energy Contract to Accelerate Critical Mineral Discovery
23/06/2026
New field-deployable approach uses engineered microbial sensors and compact imaging to "read" gold, rare earth elements, nickel, and more, cutting assay turnaround from weeks to hours WOBURN, Mass., June 23, 2026 (GLOBE [...]
Premier Health of America Announces CCAA Proceedings
23/06/2026
MONTREAL, June 23, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health” , or the “Company” ) announces proceedings under the Companies’ Creditors Arrangement Act (Canada) (the “CCAA”) [...]
Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas
23/06/2026
Sangamo intends to complete asset sale transactions through a voluntary Chapter 11 reorganization, in an effort to maximize business value for all stakeholders Lilly and Astellas to serve as “stalking horse” bidders in [...]
SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences
23/06/2026
NORTH PALM BEACH, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”) today announced a strategic investment in ARMR Sciences, a clinical-stage biodefense company [...]
SK pharmteco Announces SKyvec™, A Unified, High-Yield Viral Vector Platform Designed to Accelerate Gene Therapy Development from Batch to Bedside
23/06/2026
RANCHO CORDOVA, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced the launch of SKyvec™, its proprietary, multimodal viral vector platform. Designed to support gene therapy programs at every stage, [...]
Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
23/06/2026
Dr. Victor Fontenelle Bastos de Lima, an investigator on Nexalin’s recently completed Brazilian clinical study, received the Young Researcher Award at BRAIN 2026 – Congress on Brain, Behavior and Emotions, held in Porto [...]
Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
23/06/2026
CTA Approval from Germany's Federal Institute for Drugs and Medical Devices (BfArM), accompanied by a positive opinion from the Ethics Committee of the North Rhine Medical Association, clears Silexion to initiate the [...]
Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial
23/06/2026
Positive data supports the continued advancement of FDA Investigational New Drug (IND)- enabling development program SARASOTA, FLA., June 23, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company [...]
TOMI Reports Accelerating SteraMist Adoption as Ebola Outbreaks and Global Biosecurity Threats Drive Preparedness Spending
23/06/2026
Growing demand reflects increasing investment in scalable decontamination technologies across healthcare, emergency response, and critical infrastructure sectors FREDERICK, Md., June 23, 2026 (GLOBE NEWSWIRE) -- TOMI [...]
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
23/06/2026
Enables standardized inpatient hospital billing for QUELIMMUNE ® (SCD-PED) therapy Universal code paves the way for billing of future potential SCD therapies requiring renal replacement therapy DENVER, June 23, 2026 ( [...]
Evaluate Releases Annual World Preview Report Revealing Updated Market Forecasts for the Pharmaceutical Industry
23/06/2026
The 2026 report highlights top drivers of global pharmaceutical sales, M&A, and China’s continued impact on the industry LONDON, June 23, 2026 (GLOBE NEWSWIRE) -- Evaluate , the leading provider of market insights [...]
Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel
23/06/2026
- First glioblastoma patient ever treated with Alpha DaRT® outside of the United States, and the first in Israel - performed at Hadassah University Medical Center in Jerusalem, one of the world’s premier academic [...]
Thousands of Free HIV Tests to Support National HIV Testing Day Activities Across the United States
23/06/2026
bioLytical Laboratories is donating 4,200 INSTI® HIV Self Tests for National HIV Testing Day activities at Walgreens, marking the company's first donation of INSTI® HIV Self Tests within the USA Helping More People Know [...]
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication
23/06/2026
Publication of MONITOR-Breast study marks latest milestone for clinical validity of Precise MRD SALT LAKE CITY, June 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic [...]

Pages